1. LBA47Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511). (23rd October 2018) Authors: Lebbé, C; Meyer, N; Mortier, L; Marquez-Rodas, I; Robert, C; Rutkowski, P; Menzies, A M; Eigentler, T; Ascierto, P A; Smylie, M; Ajaz, M; Svane, I-M; Gonzalez, R; Rollin, L; Saci, A; Grigoryeva, E; Pigozzo, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1270PEfficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma. (23rd October 2018) Authors: Mignard, C; Deschamps-Huvier, A; Duval-Modeste, A-B; Dutriaux, C; Khammari, A; Avril, M-F; Mortier, L; Lesimple, T; Gaudy-Marqueste, C; Lesage, C; Machet, L; Aubin, F; Meyer, N; Beneton Benhard, N; Jeudy, G; Montaudié, H; Arnault, J-P; Leccia, M-T; Joly, P; Oncology Research Group Of The French S... Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1260PAn open-label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib for patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma. (23rd October 2018) Authors: Saiag, P; Robert, C; Grob, J J; Mortier, L; Dereure, O; Lebbe, C; Mansard, S; Grange, F; Neidhardt, E-M; Lesimple, T; Machet, L; Bedane, C; Jeudy, G; Aubin, F; Dreno, B; Szenik, A; Denden, A; Dutriaux, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 109TiPAcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types. (17th December 2018) Authors: Marabelle, A; Chevret, S; Janot, F; Escudier, B; Pouessel, D; Tournigand, C; Hoang-Xuan, K; Mortier, L; Rousseau, B J-C; Schlumberger, M J; Ray-Coquard, I L; Blay, J-Y; Niccoli, P; Jaccard, A; Couch, D; Hoog-Labouret, N; Pauporte, I; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1249PDConcomitant radiotherapy in melanoma brain metastases using the propensity score matching within the French cohort, MelBase. (23rd October 2018) Authors: Allayous, C; Oriano, B; Dalle, S; Mortier, L; Leccia, M-T; Guillot, B; Jeudy, G; Dutriaux, C; Lacour, J-P; Saiag, P; Brunet-Possenti, F; De Quatrebarbes, J; Stoebner, P-E; Legoupil, D; Beylot-Barry, M; Lesimple, T; Aubin, F; Ballon, A; Porcher, R; Lebbe, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 182TiPEXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors. (23rd October 2018) Authors: Italiano, A; Le Saux, O; André, F; Filleron, T; Spaeth, D; Heudel, P-E; Albiges, L; Bachelot, T; Gonçalves, A; Pierga, J-Y; Barlesi, F; Boige, V; Lebbe, C; Mortier, L; Frenel, J-S; Tredan, O; Jimenez, M; Legrand, F; Ferté, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1251PAdverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trial. (23rd October 2018) Authors: Atkinson, V G; Hauschild, A; Santinami, M; Mandala, M; Chiarion Sileni, V; Larkin, J; Nyakas, M S; Dutriaux, C; Haydon, A; Mortier, L; Robert, C; Schachter, J; Schadendorf, D; Feng, X; de Jong, E; Mookerjee, B; Kefford, R; Dummer, R; Kirkwood, J M; Long, G V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1250PEstimate of long-term relapse-free survival (RFS) and analysis of baseline factors associated with RFS in the COMBI-AD trial. (23rd October 2018) Authors: Dummer, R; Schadendorf, D; Hauschild, A; Santinami, M; Atkinson, V G; Mandala, M; Chiarion Sileni, V; Larkin, J; Nyakas, M S; Dutriaux, C; Haydon, A; Mortier, L; Robert, C; Schachter, J; Feng, X; de Jong, E; Mookerjee, B; Kefford, R; Kirkwood, J M; Long, G V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficiency of textile photodynamic therapy for mycosis fungoides. (September 2022) Authors: Toulemonde, E; Douxami, M; Faiz, S; Dubois, R; Verhasselt-Crinquett, M; Carpentier, O; Rached, H Abi; Mortier, L Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Photodynamic therapy for the treatment of primary cutaneous B-cell marginal zone lymphoma: a series of 4 patients. (September 2022) Authors: Toulemonde, E; Faiz, S; Dubois, R; Verhasselt-Crinquett, M; Carpentier, O; Rached, H Abi; Mortier, L Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗